Retrospective case review of missed opportunities for primary prevention of stroke and TIA in primary care: Protocol paper

BMJ Open

Volumn 4, Issue 11, 2014, Pages

  Moran, Grace M ^a   Calvert, Melanie ^a   Feltham, Max G ^a   Marshall, Tom ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BLOOD PRESSURE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; ELECTRONIC MEDICAL RECORD; EVIDENCE BASED PRACTICE; FAMILIAL HYPERCHOLESTEROLEMIA; HEART ATRIUM FIBRILLATION; HUMAN; HYPERTENSION; MEDICAL INFORMATION; PRACTICE GUIDELINE; PRIMARY MEDICAL CARE; PRIMARY PREVENTION; RETROSPECTIVE STUDY; TRANSIENT ISCHEMIC ATTACK; ADULT; AGED; FEMALE; ISCHEMIC ATTACK, TRANSIENT; MALE; MIDDLE AGED; PRIMARY HEALTH CARE; STROKE;

ADULT; AGED; FEMALE; HUMANS; ISCHEMIC ATTACK, TRANSIENT; MALE; MIDDLE AGED; PRIMARY HEALTH CARE; PRIMARY PREVENTION; RETROSPECTIVE STUDIES; STROKE;

EID: 84912039226     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2014-006622     Document Type: Article

References (38)

1. Scarborough P, Peto V, Bhatnagar P, et al. Stroke statistics. London: British Heart Foundation and Stroke Association, 2009.
2. Townsend N, Wickramasinghe K, Bhatnagar P, et al. Coronary heart disease statistics 2012 edition. London: British Heart Foundation, 2012.
3. The Lancet Editorial. Stroke-prevention is better than cure. Lancet 2007;369:247.
4. Lewington S, Clarke R, Qizilbash N, et al. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002;360:1903-13.
5. MacMahon S, Peto R, Cutler J, et al. Blood pressure, stroke, and coronary heart disease. Part 1, prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet 1990;335:765-74.
6. National Collaborating Centre for Chronic Conditions. Atrial fibrillation: national clinical guideline for management in primary and secondary care. London: Royal College of Physicians, 2006.
7. Zhang X, Patel A, Horibe H, et al. Cholesterol, coronary heart disease, and stroke in the Asia Pacific region. Int J Epidemiol 2003;32:563-72.
8. The Prospective Studies Collaboration. Cholesterol, diastolic blood pressure, and stroke: 13,000 strokes in 450,000 people in 45 prospective cohorts. Prospective studies collaboration. Lancet 1995;346:1647-53.
9. Amarenco P, Labreuche J, Lavallee P, et al. Statins in stroke prevention and carotid atherosclerosis: systematic review and up-to-date meta-analysis. Stroke 2004;35:2902-9.
10. Goldstein LB, Bushnell CD, Adams RJ, et al. Guidelines for the primary prevention of stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2011;42:517-84.
11. Brown CD, Higgins M, Donato KA, et al. Body mass index and the prevalence of hypertension and dyslipidemia. Obes Res 2000;8:605-19.
12. Hollander M, Koudstaal PJ, Bots ML, et al. Incidence, risk, and case fatality of first ever stroke in the elderly population. The Rotterdam Study. J Neurol Neurosurg Psychiatry 2003;74:317-21.
13. Appelros P, Stegmayr B, Terent A. Sex differences in stroke epidemiology: a systematic review. Stroke 2009;40:1082-90.
14. Tillin T, Hughes A, Mayet J, et al. The relationship between metabolic risk factors and incident cardiovascular disease in Europeans, South Asians, and African Caribbeans: SABRE (Southall and Brent Revisited)-A prospective population-based study. J Am Coll Cardiol 2013;61:1777-86.
15. British Cardiac Society, British Hypertension Society, Diabetes UK, HEART UK, Primary Care Cardiovascular Society, The Stroke Association. JBS 2: Joint British Societies' guidelines on prevention of cardiovascular disease in clinical practice. Heart 2005;91 (Suppl V):1-52.
16. National Institute for Health and Clinical Excellence. Lipid modification: cardiovascular risk assessment and the modification of blood lipids for the primary and secondary prevention of cardiovascular disease. NICE clinical guideline 67. National Collaborating Centre for Primary Care, 2008.
17. The Stroke Risk in Atrial Fibrillation Working Group. Independent predictors of stroke in patients with atrial fibrillation: a systematic review. Neurology 2007;69:549-54.
18. Law MR, Wald NJ, Rudnicka AR. Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and meta-analysis. BMJ 2003;326:1423-7.
19. National Institute for Health and Clinical Excellence. Hypertension: the clinical management of primary hypertension in adults. Clinical Guideline 127. National Clinical Guideline Centre, 2011.
20. Guptha SH, Shibu P, Owusu-Agyei P. Stroke prevention: missed opportunities. Lancet 369:904-5.
21. Midlov P, Ekesbo R, Johansson L, et al. Barriers to adherence to hypertension guidelines among GPs in southern Sweden: a survey. Scand J Prim Health Care 2008;26:154-9.
22. Steinman MA, Fischer MA, Shlipak MG, et al. Clinician awareness of adherence to hypertension guidelines. Am J Med 2004;117:747-54.
23. CSD Medical Research UK. CSD Medical Research UK [cited September 2014]. http://csdmruk.cegedim.com/index.html
24. British National Formulary (BNF). British National Formulary (BNF) 67 2014. http://www.bnf.org/bnf/index.htm
25. Health and Social Care Information Centre. Read Codes 2014 [cited September 2014]. http://systems.hscic.gov.uk/data/uktc/readcodes
26. CDS Health Research. The Health Improvement Network Ethics [cited September 2014]. http://www.thin-uk.com/mrec.htm
27. Maguire A, Blak B, Thompson M. The importance of defining periods of complete mortality reporting for research using automated data from primary care. Pharmacoepidemiol Drug Saf 2009;18:76-83.
28. Health and Social Care Information Centre. Quality and Outcomes Framework (QOF) 2014 [cited September 2014]. http://www.hscic. gov.uk/qof
29. Koivisto PV, Koivisto UM, Miettinen TA, et al. Diagnosis of heterozygous familial hypercholesterolemia. DNA analysis complements clinical examination and analysis of serum lipid levels. Arterioscler Thromb Vasc Biol 1992;12:584-92.
30. In Practice Systems Ltd. CVD/Stroke Risk Calculators within Vision 2012 [cited September 2014]. http://www.inps.co.uk/my-vision/user-guides-downloads/user-guides/releases/vision-releases
31. CSD Medical Research UK. THIN Data Guide for Researchers. 2013; Vol 2.6.
32. Public Health England. Strategic Health Authorities in England 2014 [cited September 2014]. http://www.swpho.nhs.uk/default.aspx? RID=27853
33. Primary Care Commissioning. QOF business rules v27 2013 [cited September 2014]. http://www.pcc-cic.org.uk/article/qof-business-rules-v27
34. Health Survey for England. Health Survey for England (HSE)-2012 adult trend tables 2012 [cited September 2014]. http://www.hscic. gov.uk/pubs/hse10trends
35. Ramsay SE, Whincup PH, Wannamethee SG, et al. Missed opportunities for secondary prevention of cerebrovascular disease in elderly British men from 1999 to 2005: a population-based study. J Public Health 2007;29:251-7.
36. McKinlay JB, Link CL, Freund KM, et al. Sources of variation in physician adherence with clinical guidelines: results from a factorial experiment. J Gen Intern Med 2007;22:289-6.
37. Mantel N. Why stepdown procedures in variable selection. Technometrics 1970;12:621-5.
38. Cabana MD, Rand CS, Powe NR, et al. Why don't physicians follow clinical practice guidelines? A framework for improvement. JAMA 1999;282:1458-65.